Send to a Friend Share

Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q4 Loss of $0.33

February 9, 2012 4:00 PM EST
ALNY Hot Sheet
Revenue Growth %: -1.4%

Financial Fact:
General and administrative: 10.41M

Today's EPS Names:
TARO, BRLI, TLB, More
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q4 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.9 million.

For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment





Follow StreetInsider.com On Twitter